CLDX

Celldex Therapeutics, Inc.

CLDX·15117B202·US·Common Stock·Healthcare - Biotechnology-13D/G

CLDX (Celldex Therapeutics, Inc.) is held by 126 institutional investors as of Q2 2026. Largest holders: WELLINGTON MANAGEMENT GROUP LLP ($355.1M), BlackRock, Inc. ($260.6M), STATE STREET CORP ($145.1M). Net institutional sentiment: Bullish.

126
Holders
(11 Elite)
$1.9B
Total Value
72% (123)
Consensus
88 buying - 35 selling
13F: Insider & Congress: Updated regularly
CLDX

Smart Money Verdict

View all
Loading verdict
Held by 126 funds
11 elite

Who's Trading

Source dates: Price Aug 27, 2026 · Insiders Dec 8, 2025 · Activists Aug 14, 2026 · Congress none

ActivistKYKynam Capital Management, LP6.8%Aug 14, 2026
ActivistT. Rowe Price Associates, Inc.T. Rowe Price Associates, Inc.6.0%Aug 14, 2026
ActivistKYKynam Capital Management, LP8.8%May 15, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
9.5M(+11.5%)$355.1M0.1%+15.04%
35
Increased
7M(+30.4%)$260.6M0.0%+45.46%
39
Increased
3.9M(+39.1%)$145.1M0.0%+17.12%
40
Decreased
3.7M(-0.7%)$138.5M0.0%+65.13%
0
Increased
3.5M(+17.0%)$128.9M0.0%+34.59%
35
Increased
2M(+19.8%)$75.3M0.0%+23.68%
35
Increased
1.6M(+63.4%)$60.1M0.0%+35.51%
43
Increased
1.2M(+77.7%)$44M0.2%+27.79%
53
Decreased
1.2M(-6.6%)$43.6M0.0%+61.00%
0
Increased
1.1M(+1.4%)$40M0.0%+52.06%
29
Increased
1M(+21.7%)$38.8M0.0%+28.41%
35
New
989,442$36.8M0.2%+9.03%
48
Decreased
985,677(-2.8%)$36.7M0.0%+49.98%
0
Decreased
917,408(-0.7%)$34.1M0.0%+49.59%
0
Increased
863,536(+37.2%)$32.1M0.0%+30.10%
38
Increased
788,696(+438.3%)$29.3M0.0%+13.73%
46
Increased
719,647(+24.7%)$26.8M0.0%+19.20%
35
Increased
700,830(+40.1%)$26.1M0.1%+30.26%
38
Increased
661,235(+382.6%)$24.6M0.0%+17.59%
46
Increased
655,954(+20.3%)$24.4M0.0%-1.89%
34

Showing 1-20 of 134

1 / 7
CLDXCLDXCelldex Therapeutics, Inc.

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used